✦ LIBER ✦

A phase I trial and pharmacokinetic study of a 24-hour infusion of trabectedin (Yondelis®, ET-743) in children and adolescents with relapsed or refractory solid tumors

✍ Scribed by Meredith K. Chuk; Alberta Aikin; Trish Whitcomb; Brigitte C. Widemann; Peter Zannikos; Eliel Bayever; Frank M. Balis; Elizabeth Fox

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I trial of weekly trabectedin (ET-

✍ Wells A. Messersmith; Antonio Jimeno; David Ettinger; Dan Laheru; Julie Brahmer; 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 316 KB

Phase I and pharmacokinetic study of Yon

✍ C. Twelves; K. Hoekman; A. Bowman; J.B. Vermorken; A. Anthoney; J. Smyth; C. van 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 279 KB

Phase I clinical study of ecteinascidin-

✍ Taamma, A.; Cvilkovic, E.; Jimeno, J.; Gasparetto, M.; Meeley, K.; Vega, E.; Cam 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 404 KB

Phase I trial and pharmacological study

✍ Doz, F; Gentet, J C; Pein, F; Frappaz, D; Chastagner, P; Moretti, S; Vassal, G; 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 86 KB

Phase 2 trial of pemetrexed in children

✍ Anne B. Warwick; Suman Malempati; Mark Krailo; Allen Melemed; Richard Gorlick; M 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

A phase I trial of vorinostat and bortez

✍ Jodi A. Muscal; Patrick A. Thompson; Terzah M. Horton; Ashish M. Ingle; Charlott 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB